Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis

Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation

(2017) Koji Matsuo et al.   INTERNATIONAL JOURNAL OF CANCER

The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review

(2017) Munetaka Takekuma et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma

(2016) Yifan Li et al.   CANCER

Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy

(2016) Munetaka Takekuma et al.   International Journal of Clinical Oncology

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505

(2015) Ryo Kitagawa et al.   JOURNAL OF CLINICAL ONCOLOGY

Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer

(2015) Munetaka Takekuma et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Current Surgical Principle for Uterine Cervical Cancer of Stages Ia2, Ib1, and IIa1 in Japan

(2013) Mikio Mikami et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study

(2012) J. Sehouli et al.   ANNALS OF ONCOLOGY

Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study

(2012) Munetaka Takekuma et al.   GYNECOLOGIC ONCOLOGY

Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy

(2011) Masayoshi Hosaka et al.   JOURNAL OF SURGICAL ONCOLOGY

Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition

(2010) Satoru Nagase et al.   International Journal of Clinical Oncology

Interdisciplinary S2k guideline on the diagnosis and treatment of cervical carcinoma

(2009) Matthias W. Beckmann et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

(2009) Bradley J. Monk et al.   JOURNAL OF CLINICAL ONCOLOGY